U.S. markets open in 2 hours 27 minutes

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.7500-0.0200 (-2.60%)
At close: 3:36PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7700
Open0.0000
Bid0.7300 x 0
Ask0.7500 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume36,297
Market Cap24.8M
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)-0.1060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar 08, 2016
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Canntab Announces Closing of Convertible Debenture Private Placement
      Newsfile

      Canntab Announces Closing of Convertible Debenture Private Placement

      Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the "Offering") of secured convertible debentures of the Company ("Convertible Debentures"), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the "Convertible Debentures"). The ...

    • Canntab Begins Delivery of Tablets to MediPharm
      PR Newswire

      Canntab Begins Delivery of Tablets to MediPharm

      Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its first delivery of two (2) of a total of five (5) SKU's ordered by MediPharm Labs Corp. (TSE:LABS.TO) (OTC:MEDIF). Further to Canntab's press release dated June 2, 2020, the Company confirms that the total purchase order is approximately $1.3 Million. Canntab intends to complete and deliver the entire order by the end of 2020.

    • CNW Group

      COVID-19 Pandemic - The government presents its daily update

      QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.